Tag Archives: DLR

Top Stocks To Watch For 2019

There are well over 100 different majors college students can potentially choose, and it’s no big secret that graduating college will generally boost your earnings power. Having said that, there’s a huge difference in earning power among the choices. Not only do some earn dramatically more than others, but many fields have minuscule unemployment rates and some high-earning fields don’t require education beyond a bachelor’s degree to attain a six-figure salary.

With that in mind, a recent Bankrate report examined 162 college majors and the Americans who hold degrees....More>>>

Top 10 Financial Stocks To Buy Right Now

Image source: The Motley Fool.

Endurance International Group Holdings Inc  (NASDAQ:EIGI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 8:00 a.m. ET

Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:

Operator

Good day ladies and gentlemen, and welcome to the Endurance International Group 2018 Fourth Quarter and Full-Year Results Financial Results Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. (Operator....More>>>

Hot Financial Stocks To Invest In 2019

Shares of Hilton Hotels Co. (NYSE:HLT) have been assigned an average rating of “Buy” from the twenty-one ratings firms that are currently covering the stock, Marketbeat.com reports. Nine research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $87.07.

HLT has been the topic of several recent research reports. Sanford C. Bernstein cut shares of Hilton Hotels from an....More>>>

Best Value Stocks To Watch For 2019

Shares of Sarepta Therapeutics (SRPT) have gotten crushed today after the FDA offered a negative take on Sarepta’s Duchenne muscular dystrophy drug. In fact, Leerink’s Joseph Schwartz and team contend that Sarepta’s “dystrophin argument strongly challenged and largely invalidated by the FDA.” They explain:

Andrew Harnik/Associated Press

The updated FDA review is even more negative on the historical control data. 4-yr. clinical effectiveness data submitted in January at the time was considered as major amendment to eteplirsen NDA that had resulted in....More>>>

Best Heal Care Stocks To Own For 2018

Can The “Tech Summit” Cause A Short Squeeze In TSLA Stock?

Tesla (NSDQ:TSLA) stock has declined by 20% YTD, massively underperforming the market. But while investors are reluctant to invest in the stock, Tesla has been one of the favorite stocks of short traders for some time now. In the latest fortnight, the short interest in TSLA stock jumped by 13% to35.68 million, a massive 32% of the float, with days to cover increasing from 6 days to 8 days. Since August, short interest has jumped by almost 35%. With days to cover rising to 8 days, a strong positive news may lead to....More>>>